Compugen Up 9.8% After Hitting 52-Week High (CGEN)

Shares of Compugen Ltd. CGEN are trading up 9.8% at $5.60 per share during the Friday afternoon trading session. The day's trading range for shares of Compugen Ltd has been between $5.09 and a 52-week high of $5.77 per share. Trading volume for Compugen Ltd. (CGEN) has been extremely heavy, with 605,000 shares having been traded today, nearly 6 times the daily average volume of 107,000 shares. Compugen Ltd is a leading drug and diagnostic product candidate discovery company. Unlike traditional high throughput trial and error experimental based discovery, Compugen's discovery efforts are based on in silico (by computer) product candidate prediction and selection utilizing a broad and continuously growing infrastructure of proprietary scientific understandings and predictive platforms, algorithms, machine learning systems and other computational biology tools to address important unmet therapeutic and diagnostic needs – both for Compugen and its partners. Read more from Benzinga's Company news.